Thyroid cancer review 3: management of medullary and undifferentiated thyroid cancer.
This is the last of the three review articles dealing with thyroid cancer. Over 90% of thyroid cancer is of the differentiated type associated with a very good 10-year disease-free survival rate. In contrast, the rare forms of thyroid cancer which comprise medullary thyroid cancer arising from parafollicluar C cells, Hurthle cell carcinoma, anaplastic carcinoma, thyroid lymphoma and squamous cell carcinoma are typically associated with a poorer survival rate. Management is based upon small retrospective cohort studies.
Nix
P A
PA
Department of Otolaryngology, Head and Neck Surgery, York Hospital, York, UK.
Nicolaides
A
A
Coatesworth
A P
AP
D002277:Carcinoma / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis; D009367:Neoplasm Staging / Q000379:methods; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*